Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

P Sharma, A P Weston, T Morales, M Topalovski, M S Mayo, R E Sampliner, P Sharma, A P Weston, T Morales, M Topalovski, M S Mayo, R E Sampliner

Abstract

Background: Biopsy specimens obtained from the gastro-oesophageal junction can reveal intestinal metaplasia in patients presenting for routine upper endoscopy. The site of biopsy may play a critical role in determining the dysplasia risk of a patient.

Aims: To evaluate prospectively the dysplasia risk in patients with intestinal metaplasia of the distal oesophagus or within the gastric cardia.

Methods: Patients with short segment Barrett's oesophagus (SSBO) and cardia intestinal metaplasia (CIM) were followed prospectively.

Results: 177 patients with SSBO were identified (mean age 62 years, range 38-82; 91% whites). Twenty prevalence cases of dysplasia in SSBO were detected: 17 low grade dysplasia (LGD), three high grade dysplasia (HGD). Seventy six patients with CIM were identified (mean age 67 years, range 37-81; 81% whites). A single prevalence case of LGD in CIM was detected. During follow up of 78 SSBO and 34 CIM patients, dysplasia developed in nine (seven LGD, two HGD) with SSBO and in one (LGD) with CIM. There were significant differences between the two groups with respect to age, ethnicity, dysplasia prevalence, and incidence. Time to dysplasia progression was significantly longer in CIM compared with SSBO patients. Of the five patients with SSBO and HGD, one developed adenocarcinoma of the oesophagus on follow up. No HGD or cancers have been detected over this time period in CIM patients.

Conclusions: The dysplasia risk is significantly greater in SSBO than in CIM patients, indicating two potentially different clinical processes. Future studies should separate SSBO from CIM in order to enhance the understanding of the pathophysiology and malignant potential of each entity.

Figures

Figure 1
Figure 1
Dysplasia free interval. SSBO, short segment Barrett's oesophagus; CIM, cardia intestinal metaplasia.
Figure 2
Figure 2
Outcome of dysplasia in patients with short segment Barrett's oesophagus. HGD, high grade dysplasia; LGD, low grade dysplasia

References

    1. Dig Dis Sci. 1992 Jan;37(1):137-43
    1. JAMA. 1991 Mar 13;265(10):1287-9
    1. Gastroenterology. 1993 Feb;104(2):510-3
    1. JAMA. 1993 Sep 15;270(11):1320
    1. Arch Surg. 1994 Jun;129(6):609-14
    1. Lancet. 1994 Dec 3;344(8936):1533-6
    1. Am J Gastroenterol. 1996 May;91(5):981-6
    1. Am J Gastroenterol. 1996 Aug;91(8):1507-11
    1. Am J Gastroenterol. 1997 Mar;92(3):407-13
    1. Am J Gastroenterol. 1997 Mar;92(3):414-8
    1. Dig Dis Sci. 1997 Mar;42(3):603-7
    1. Am J Gastroenterol. 1997 Nov;92(11):2012-6
    1. Gastroenterology. 1998 Apr;114(4):633-9
    1. Gut. 1998 May;42(5):659-62
    1. Am J Gastroenterol. 1998 Jul;93(7):1033-6
    1. Gut. 1998 Jul;43(1):17-21
    1. Gastroenterology. 1999 Feb;116(2):277-85
    1. Hum Pathol. 1983 Nov;14(11):931-68
    1. N Engl J Med. 1986 Aug 7;315(6):362-71
    1. Gastrointest Endosc. 1987 Dec;33(6):413-6
    1. Hum Pathol. 1988 Aug;19(8):942-8
    1. Gastroenterol Clin North Am. 1991 Dec;20(4):817-34

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir